LilyLink was founded to modernize high-risk prenatal care with tech-enabled solutions that help practices and their patients feel empowered and supported.
Through this purpose, we strive to promote safer pregnancies and healthier newborns.
Drawing from their individual experiences, our founders identified frustrating gaps in the way gestational diabetes is managed.
Existing solutions focused on either diabetes or pregnancy, which created unnecessary burden on both provider and patient.
LilyLink brings purpose-built modern technology to maternal diabetes care.
Tyler Rice
Co-Founder, CEO
Madison Stanford
Co-Founder, CTO
Tyler Rice
Co-Founder, CEO
Madison Stanford
Co-Founder, CTO
With science at our core, we design technology according to the most recent and best available evidence, ensuring our commitment to clinical safety and efficacy.
We believe deeply in the societal and economic value of advancing women's health through improved prenatal care, and operate always from this frame of reference.
Better outcomes are achieved through empathy. There exists a diverse set of views around pregnancy, and we work to meet patients and providers where they are.
We will operate ethically, promote and maintain transparency, and make informed decisions that serve the interests of our clients and their patients.
